Schwab Network on $MRNA (Nov 5, 2026)

Your last name here is also in the healthcare sector, but it's a pharmaceutical company that has fallen a little more than some of the others, down 4.3% for Moderna, which has been making headlines a lot so far this year.

Well, the big picture for Moderna: everyone knows them from their COVID vaccine, but they also have some cool things they're working on, like the partnership with Keytruda and the drug they've provided that's reached Phase 3, which currently shows it can reduce skin cancer-related deaths by about 42%.

So, this is good news. So, I like Moderna in a long-term trend, I shouldn't say a long-term upward trend. It has been on an upward trend since the beginning of this year.

My trade in this, "Pulse Put Spread", January 15, 2027. You want to own the put option at 200, and you want to sell the put option at 210 to someone else. Again, we are looking at a price difference of about $4 there.

You have about 71 days. Again, the stock can go up, move sideways, or go down, and you will still be a winner.

That's right, we reached our highest levels here, our old highs near 255. We were unable to maintain our level above that level here. We still have a sharp upward trend line in white, but we now find ourselves once again within the boundaries of the original upward channel shape here.

Our low point here, the bottom of our red candle near 217, stands out as a potential support area if we continue to falter . Our 5-day exponential moving average in dark blue, 238.25, is also very closely aligned with this trend line.

So, if we break below that, it could open the door for our 21-day monthly exponential moving average near 219.

The Relative Strength Index (RSI) is a bit confused at the moment. We still have our short upward trend line in green in play, but we also have a longer downward trend line in red here which we have failed to break through.

It seemed like it would happen, but now we're back to below that level as well. Therefore, look for a stronger trend breakout beyond either of them to get more indications of our ultimate bullish or bearish direction here.

So, our trading volume profile shows a node here and here. Therefore, the 220 and 200 levels are approximately points of interest in relation to our analysis of the intense trading activity here.

Well, Moderna is down 4.5% at 246.38 at the moment, but certainly not as much as we've seen in some of the other stocks we're watching today in this sell-off.